Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study
Intestinal Failure · 2024
DOI: 10.1016/j.intf.2024.100027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intestinal Failure, 2024. Verfasst von María Inés Martínez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Nutrición, Hospital de Niños Sor María Ludovica, La Plata, Argentina. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Current treatment of patients with chronic intestinal failure due to short bowel syndrome (CIF-SBS) attempts to promote the intestinal adaptation process. Teduglutide (TED) is the first successful pharmacological intervention which enhances natural intestinal adaptation.
Aim
To present the long-term results and follow up of all the children treated with TED at specialized intestinal failure units in Argentina.
Methods
Multicenter, descriptive, retrospective study of patients aged 1-18 years with CIF-SBS, that initiated TED in specialized centers in Argentina. Sex, age, SBS etiology/anatomy, remaining small bowel length (RBL), 20 % decrease in initial parenteral nutrition (PN) volume, and weaning at 3-6-12 months of treatment are described.
Results
Thirty-three patients (11 female) treated with TED between 1/2017 and 8/2023 in 9 centers were included. Median time of CIF-SBS prior to TED was 6.06 (IQR 3.8-10.4) years. Median age at starting TED was 7.5 (IQR 4.8-12.4), range 2.5-18 years. Anatomy types: type 1 in 1; type 2 in 22, and type 3 in 9. Median time of treatment was 1.5 (IQR 0.52-3.2) years.A 20 % reduction of the initial weekly PN volume was obtained in 23 patients (70 %) and complete PN discontinuation without detriment of the nutritional status was achieved in 36 % during the entire follow-up period.The most frequent adverse event was mild abdominal pain, and two patients discontinued the medication due to adverse events.
Conclusions
The Argentine experience with TED as part of the intestinal rehabilitation strategies showed good results and adverse events like those reported in other international series.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Servicio de Nutrición, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
- Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
- Servicio de Nutrición y Diabetes, Hospital JP Garrahan, Buenos Aires, Argentina.
- Unidad de Rehabilitación Intestinal y Trasplante de Intestino, Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina.
- Servicio de Clínica y Soporte Nutricional del Hospital Público Materno Infantil, Salta, Argentina.
- Clínica Pediátrica San Lucas. Servicio de Nutrición, Neuquén, Neuquén, Argentina.
Zitieren
APA
Martínez, M. I., Busoni, V., Saure, C., Dlugosewsky, C., Dalieri, M., Cosentino, S., Balacco, M., Rudi, L., Fernandez, A., & Rumbo, C. (2024). Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study. Intestinal Failure. https://doi.org/10.1016/j.intf.2024.100027
Vancouver
Martínez MI, Busoni V, Saure C, Dlugosewsky C, Dalieri M, Cosentino S, et al. Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study. Intestinal Failure. 2024. doi:10.1016/j.intf.2024.100027
BibTeX
@article{Martnez2024,
author = {Martínez, María Inés and Busoni, Verónica and Saure, Carola and Dlugosewsky, Corina and Dalieri, Marcela and Cosentino, Sandra and Balacco, Martín and Rudi, Lorena and Fernandez, Adriana and Rumbo, Carolina},
title = {Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study},
journal = {Intestinal Failure},
year = {2024},
doi = {10.1016/j.intf.2024.100027}
}
EUVIMED